Investigation into the effects of FK352 (a novel adenosine-1 receptor antagonist) in cirrhotic patients with ascites: A pilot study

被引：0
|
作者：
Stanley, AJ [1 ]
Forrest, EH [1 ]
Dabos, KJ [1 ]
Hayes, PC [1 ]
机构：
[1] ROYAL INFIRM,DEPT MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1284 / 1284
页数：1
相关论文
共 50 条
  • [31] Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
    Seitz, Lisa
    Jin, Lixia
    Leleti, Manmohan
    Ashok, Devika
    Jeffrey, Jenna
    Rieger, Aimee
    Tiessen, Renger G.
    Arold, Gerhard
    Tan, Joanne B. L.
    Powers, Jay P.
    Walters, Matthew J.
    Karakunnel, Joyson
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 711 - 721
  • [32] Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
    Lisa Seitz
    Lixia Jin
    Manmohan Leleti
    Devika Ashok
    Jenna Jeffrey
    Aimee Rieger
    Renger G. Tiessen
    Gerhard Arold
    Joanne B. L. Tan
    Jay P. Powers
    Matthew J. Walters
    Joyson Karakunnel
    Investigational New Drugs, 2019, 37 : 711 - 721
  • [33] The Effect of Anakinra, an IL-1 Receptor Antagonist, in Patients with Inclusion Body Myositis (sIBM): A Small Pilot Study
    Kosmidis, Michalis
    Alexopoulos, Haralampos
    Drosos, Alexandros
    Tzioufas, Athanasios
    Dalakas, Marinos
    NEUROLOGY, 2012, 78
  • [34] A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants
    Gupta, Pranav
    Chatterjee, Manash
    Kim, Yeonil
    Deschamps, Kathleen
    Lemoine, Lieselotte
    Van Dyck, Kristien
    Matthews, Catherine Zhou
    Rottey, Sylvie
    Stoch, Aubrey
    Lai, Eseng
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 492 - 499
  • [35] The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
    Kosmidis, Michalis L.
    Alexopoulos, Harry
    Tzioufas, Athanasios G.
    Dalakas, Marinos C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 334 (1-2) : 123 - 125
  • [36] EFFECTS OF THE ADENOSINE A1-ANTAGONIST ROLOFYLLINE ON RENAL FUNCTION IN ACUTE HEART FAILURE PATIENTS: RESULTS FROM THE PROTECT STUDY
    Voors, Adriaan A.
    Dittrich, Howard C.
    Massie, Barry M.
    DeLucca, Paul
    Mansoor, George
    Givertz, Michael M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [37] PROTECTIVE EFFECTS OF KW-3902, A NOVEL ADENOSINE A(1)-RECEPTOR ANTAGONIST, AGAINST GENTAMICIN-INDUCED ACUTE-RENAL-FAILURE IN RATS
    YAO, K
    KUSAKA, H
    SATO, K
    KARASAWA, A
    JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 65 (02): : 167 - 170
  • [38] Pilot-scale synthesis of a novel non-xanthine adenosine A1 receptor antagonist.: 1,3-Dipolar cycloaddition of pyridine N-imine to an acetylene
    Zanka, A
    Hashimoto, N
    Uematsu, R
    Okamoto, T
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1998, 2 (05) : 320 - 324
  • [39] Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Chronic Heart Failure Patients 10/2/08
    Mitrovic, Veselin
    Seferovic, Petar
    Dodic, Slobodan S.
    Devoogd, Hanka
    Boecker, Christiane
    Ziegler, Dieter
    Godes, Michael
    Essers, Hans
    Hocher, Berthold
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) : 798 - 799
  • [40] A euglycaemic clamp pilot study assessing the effects of the glucagon receptor antagonist LY2409021 on 24-hour insulin requirement in patients with type 1 diabetes mellitus
    Kapitza, C.
    Garhyan, P.
    Ding, Y.
    Kelly, R. P.
    Hardy, T. A.
    Kazda, C. M.
    DIABETOLOGIA, 2013, 56 : S235 - S235
12345